PDX Pharmaceuticals Inc
PDX Pharmaceuticals Inc is a small business in Portland, OR registered on SAM.gov to bid on federal contracts. It has won 9 small business R&D awards worth $9.2 million through the SBIR and STTR programs since 2017, according to SBIR.gov.
- UEI
- VTX7JRKLC3F5
- CAGE code
- 66ST6
- SAM.gov registration
- Active
Registration details
| Legal business name | PDX Pharmaceuticals Inc |
|---|---|
| Unique Entity ID (UEI) | VTX7JRKLC3F5 |
| CAGE code | 66ST6 |
| Location | Portland, OR |
| SAM.gov registration | Active through Sep 15, 2027 |
| Business started | 2010 |
| Primary NAICS code | 541713: Research and Development in Nanotechnology |
| Website | www.pdxpharm.com |
Certifications and business types
- Minority-owned (self-reported in SAM.gov)
- Women-owned (self-reported in SAM.gov)
- Women-owned small business (self-reported in SAM.gov)
SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
PDX Pharmaceuticals Inc has won 9 small business R&D awards worth $9.2 million through the SBIR and STTR programs since 2017, 5 of them Phase II. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Sep 5, 2024 | NIH | SBIR Phase II Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatment | $250,000 |
| Sep 1, 2024 | NIH | SBIR Phase II PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer | $2.2 million |
| Jul 6, 2023 | NIH | SBIR Phase I PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer | $400,000 |
| Dec 1, 2022 | NIH | SBIR Phase II Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer | $1.9 million |
| Sep 23, 2021 | NIH | SBIR Phase I Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer | $378,030 |
| Sep 1, 2021 | NIH | SBIR Phase II In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune… | $2 million |
| Jun 1, 2018 | NIH | SBIR Phase II Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast… | $1.5 million |
| Aug 15, 2017 | NIH | SBIR Phase I Development of topical formulation of siRNA nanoparticle for treating skin diseases | $325,000 |
Showing the newest 8. Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes PDX Pharmaceuticals Inc is small under
On its SAM.gov registration, PDX Pharmaceuticals Inc meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
Open contracts in PDX Pharmaceuticals Inc's NAICS codes
38 open federal opportunities on SAM.gov use a NAICS code PDX Pharmaceuticals Inc is small under. These are due soonest.
- SURPASS Webinar and Proposers' Day Information
Due in 2 daysOct 12, 2026
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Due in 2 daysOct 12, 2026
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Due in 3 daysOct 14, 2026
- Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United States Biotechnology Leadership
Due in 4 daysOct 15, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
Similar small businesses
Other small businesses with the same primary NAICS code (541713) that have won federal contracts, starting with Oregon:
- Eccalon, LLC, Hanover, MD
- Chenega Supply Chain Solutions, LLC, Chesapeake, VA
- SNC Therapeutics, Inc., Evanston, IL
- Xuv Lasers, Inc., Fort Collins, CO
- Tao Treasures, LLC, Frederick, MD
- Supercool Metals Inc., Branford, CT
Frequently asked questions
What is PDX Pharmaceuticals Inc's CAGE code?
PDX Pharmaceuticals Inc's CAGE code is 66ST6. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is PDX Pharmaceuticals Inc's UEI?
PDX Pharmaceuticals Inc's Unique Entity ID (UEI) is VTX7JRKLC3F5. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is PDX Pharmaceuticals Inc's SAM.gov registration active?
Yes, as of the latest SAM.gov public data, PDX Pharmaceuticals Inc's registration is active through Sep 15, 2027. Registrations are renewed every year.
Is PDX Pharmaceuticals Inc a small business?
PDX Pharmaceuticals Inc is registered on SAM.gov as small under 2 NAICS codes, including its primary code, 541713. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.